BD Sponsored Session: The Vital Role of Blood Culture Quality & Phenotypic ID/AST Results on Sepsis Patient Outcomes

Description: 

Date/Time: April 11, 2024 | 11:30 am - 12:00 pm ET

Note: This session will not be available for review after the conference. Slides will not be available.

Enhancing sepsis patient outcomes in the context of increasing antimicrobial resistance requires continuous quality and performance improvement initiatives across the hospital. This sponsored session will focus on those improvements from the perspective of the clinical microbiology laboratory. Despite best efforts, hospitals are still having blood culture collection issues, including specimen contamination, low blood fill volume, and an inappropriate number of blood culture sets collected, which results in costly redraws, lab re-work, and delays in patient care. An efficient bloodstream infection diagnostic pathway begins with high-quality blood culture samples and ends with accurate pathogen identification and antimicrobial susceptibility testing, which informs patient care. Antimicrobial stewardship programs, combined with rapid diagnostics, are critical to optimize the use of antibiotics, effectively treat infections, protect patients from harms caused by unnecessary antibiotic use, reduce the risk of developing antibiotic resistance, and reduce hospital costs and length of stay.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.